Carl Hawkins, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1140 N State St, Saint Ignace, MI 49781 Phone: 906-643-0466 Fax: 906-643-0464 |
Dr. Timothy D Hoffmann, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1140 N State St, Suite 2805, Saint Ignace, MI 49781 Phone: 906-643-8689 Fax: 906-643-6716 |
Alice Lindsey, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 220 Burdette St, Saint Ignace, MI 49781 Phone: 906-643-0400 Fax: 906-643-6188 |
Lauren Kaye Buhr, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1140 N State St, Saint Ignace, MI 49781 Phone: 906-643-8585 |
John Stephenson, M.C. Family Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1140 N State St, Saint Ignace, MI 49781 Phone: 906-643-0402 Fax: 906-643-0463 |
Dr. Lene A Heinlen, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1140 N State St, Saint Ignace, MI 49781 Phone: 906-328-2148 |
Christopher John Gunnell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1140 N State St, Saint Ignace, MI 49781 Phone: 906-643-8585 Fax: 906-643-0414 |
News Archive
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced the presentation of positive preclinical data for delafloxacin in four poster sessions at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Omega-3 fatty acids are able to stimulate the activation of brown and beige adipose tissues, a discovery that would promote the development of new therapies for obesity and other metabolism diseases, according to a research study published in the journal Nature Communications under the supervision of Professor Francesc Villarroya, from the Department of Biochemistry and Molecular Biomedicine and the Biomedical Research Center Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN) of the Institute of Health Carlos III.
A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.
With the thermometer dropping and the onset of flu season upon us, AARP is reaching out to their membership and the public to encourage them to get a seasonal flu vaccine this year.
› Verified 2 days ago